Fecal Microbiota Transplantation National Registry

The AGA Fecal Microbiota Transplantation (FMT) National Registry will assess short- and long-term patient outcomes associated with FMT. This registry is a program of the AGA Institute and AGA Center for Gut Microbiome Research & Education.

If you perform fecal microbiota transplantation (FMT), we encourage you to participate in this national data collection project. Our goal is to track 4,000 patients for 10 years. The data we collect will allow us to identify potential short-term adverse outcomes and to search for long-term safety concerns, such as development of chronic conditions like irritable bowel syndrome, obesity and diabetes. Please contribute to advancing the future of FMT — the information available to you and your patients at the end of this initiative will be worth it.

AGA releases first results from the NIH-funded AGA FMT National Registry

Published in Gastroenterology, the registry reported that FMT led to a cure of C. difficile infection in 90% of patients across 20 North American FMT practice sites. Few serious side effects were reported.

Largest planned fecal microbiota transplantation (FMT) study enrolls 1st patient

With this milestone, the FMT registry is officially underway. The AGA FMT National Registry also announces collaborations with American Gut and OpenBiome.

Big data meets big doo-doo

Genome Magazine profiles AGA’s Fecal Microbiota Transplantation National Registry, which will be the largest data set of long-term outcomes for this procedure.

AGA’s Fecal Microbiota Transplantation National Registry: an important step toward understanding risks and benefits of microbiota therapeutics

In this Gastroenterology commentary, the registry co-principal investigators discuss the impetus and goals for this massive data collection initiative.

AGA Establishes NIH-Funded Registry to Track Fecal Microbiota Transplants

Read our initial announcement of the AGA FMT National Registry.

Are you a patient interested in participating in this registry?

Visit Clinicaltrials.gov to see the sites participating in this registry. You or your doctor can contact the participating sites to learn more about enrolling.

Are you a patient already enrolled in this registry?

Visit this page for frequently asked questions and other information relevant to patients who have already received a FMT.

FMT information for patients

This information will help you understand if fecal microbiota transplantation is right for you.

Understanding fecal microbiota transplantation

Watch this brief video to hear as leading experts in the field explain what are fecal transplants and how they’ve changed the treatment of recurring C. difficile infection.

More on the AGA FMT National Registry

Hear from Loren Laine, MD, AGAF, Colleen Kelly, MD, and Gary Wu, MD, co-principal investigators for AGA’s NIH-funded FMT registry, as they explain how this registry will influence future practice and research of FMT.

Meet our funder

This project is supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number R24AI118629.

The content on this website is solely the responsibility of the American Gastroenterological Association and does not necessarily represent the official views of the National Institutes of Health.

Meet our partner societies

Meet our registry collaborators

Meet our steering committee

The FMT Registry Steering Committee oversees registry operations, ensures compliance with clinical protocol and applicable regulations, and provides general direction for the registry.

Headshot of Colleen Kelly MD

Colleen Kelly, MD, Co-Chair and Prinicipal Investigator, Brown University Women’s Medicine and Collaborative

Headshot of Loren Laine MD AGAF

Loren Laine, MD, AGAF, Co-Chair and Co-Principal Investigator, Yale School of Medicine

Headshot of WU Gary MP

Gary Wu, MD, Co-Principal Investigator, University of Pennsylvania

Headshot of Ashish Atreja

Ashish Atreja, MD, Health Information Technology Expert, Mount Sinai Hospital

Headshot of Sarah Khan

Stacy Kahn, MD, NASPGHAN Liaison, Boston Children’s Hospital

Default Avatar Icon

James Lewis, MD, MSCE, AGAF, Clinical Epidemiology Expert, University of Pennsylvania

Default Avatar Icon

Thomas Moore, MD, IDSA Liaison, Infectious Disease Consultants of Kansas

Headshot of Dr Rubin

David Rubin, MD, AGAF, CCFA Liaison, University of Chicago

Brought to you by the

AGA Center for Gut Microbiome Research & Education